Literature DB >> 9365764

In vitro transendothelial migration of blood T lymphocytes from HIV-infected individuals.

J J Saukkonen1, S Furfaro, K M Mahoney, R M Strieter, M Burdick, E A Wright, H Kornfeld, J S Berman.   

Abstract

OBJECTIVE: We hypothesized that differential extravasation of circulating CD4+ or CD8+ T lymphocytes contributes to HIV-associated CD8+ lymphocytic alveolitis. Differences in T-cell transendothelial migration may be intrinsic or emerge at sites where vascular endothelium is activated by overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma.
DESIGN: We used an in vitro model of lymphocyte extravasation to assess transendothelial migration of peripheral blood mononuclear cells (PBMC) from HIV-positive individuals. We assayed bronchoalveolar lavage (BAL) fluid from HIV-positive and normal individuals to determine if increased levels of TNF-alpha and IFN-gamma were present in the lungs of HIV-infected individuals.
METHODS: Transendothelial migration was assessed by determining the number and flow cytometric phenotype of PBMC adherent to or migrating across unstimulated or TNF-alpha and IFN-gamma-activated endothelial cell monolayers. We measured BAL fluid cytokine concentrations using standard antigen-capture enzyme-linked immunosorbent assays for TNF-alpha and IFN-gamma.
RESULTS: T cells migrating across unactivated endothelial cells were significantly enriched for CD4+ T cells. Cytokine activation of endothelial cells allowed significantly greater transendothelial migration of CD8+ T cells compared to unactivated endothelial cells. TNF-alpha was increased in BAL fluid from HIV-positive individuals relative to controls.
CONCLUSIONS: These data suggest that, in HIV-positive individuals, CD4+ T cells are migration competent and blood CD8+ T cells do not have enhanced migration competence relative to CD4+ T cells. CD8+ T cell extravasation is aided by TNF-alpha and IFN-gamma-induced endothelial cells activation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365764     DOI: 10.1097/00002030-199713000-00008

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.

Authors:  Crystal R Leibrand; Jason J Paris; Austin M Jones; Quamrun N Masuda; Matthew S Halquist; Woong-Ki Kim; Pamela E Knapp; Angela D M Kashuba; Kurt F Hauser; MaryPeace McRae
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

Review 2.  HIV and viral protein effects on the blood brain barrier.

Authors:  MaryPeace McRae
Journal:  Tissue Barriers       Date:  2016-01-28

Review 3.  Treating viruses in the brain: Perspectives from NeuroAIDS.

Authors:  Melanie R Nicol; MaryPeace McRae
Journal:  Neurosci Lett       Date:  2021-01-30       Impact factor: 3.046

4.  HIV associated Lymphocytic Interstitial Pneumonia: a clinical, histological and radiographic study from an HIV endemic resource-poor setting.

Authors:  Richard N van Zyl-Smit; Jashira Naidoo; Helen Wainwright; Quanita Said-Hartley; Malika Davids; Hillel Goodman; Sean Rogers; Keertan Dheda
Journal:  BMC Pulm Med       Date:  2015-04-22       Impact factor: 3.317

Review 5.  Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis.

Authors:  Nikhil Chakravarty; Thrisha Senthilnathan; Sophia Paiola; Priya Gyani; Sebastian Castillo Cario; Estrella Urena; Akash Jeysankar; Prakash Jeysankar; Joseph Ignatius Irudayam; Sumathi Natesan Subramanian; Helen Lavretsky; Shantanu Joshi; Gustavo Garcia; Arunachalam Ramaiah; Vaithilingaraja Arumugaswami
Journal:  FEBS Lett       Date:  2021-11-22       Impact factor: 3.864

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.